ALAlphabet Inc.

Institutional investor · Portfolio as of Q1 2023

Top Holdings49 positions

Checking export access…
Activity:

UIPATH INC

14.1M$247M13.7%$67.93-74.15%
8 qtrssince 2021-Q2
Unchanged
0

PRIME MEDICINE INC

13.3M$163.4M9.1%$18.58-33.80%
2 qtrssince 2022-Q4
Unchanged
0

CROWDSTRIKE HLDGS INC

1.2M$159.7M8.9%$30.04+14.22%
2 qtrssince 2022-Q4
Increased
93

OSCAR HEALTH INC

24M$157.2M8.7%$26.88-75.67%
9 qtrssince 2021-Q1
Unchanged
0
VERVVERVDelisted

VERVE THERAPEUTICS INC

10.5M$152.1M8.4%——
8 qtrssince 2021-Q2
Unchanged
0

DEXCOM INC

1.3M$145.2M8.1%$77.24+50.41%
15 qtrssince 2019-Q3
Unchanged
0

PLANET LABS PBC

31.9M$125.5M7.0%$6.15-36.10%
6 qtrssince 2021-Q4
Unchanged
0
EQRXEQRXDelisted

EQRX Inc

47.7M$92.5M5.1%——
6 qtrssince 2021-Q4
Unchanged
0

SNOWFLAKE INC

535,604$82.6M4.6%$229.13-32.66%
5 qtrssince 2022-Q1
Unchanged
0

DUOLINGO INC

523,824$74.7M4.1%$109.82+30.16%
7 qtrssince 2021-Q3
Decreased
0

GITLAB INC

1.9M$66.3M3.7%$44.12-22.28%
4 qtrssince 2022-Q2
Increased
76

FRESHWORKS INC

4M$62M3.4%$26.26-41.51%
6 qtrssince 2021-Q4
Unchanged
0

ROBINHOOD MKTS INC

4.9M$47.9M2.7%$42.08-76.92%
7 qtrssince 2021-Q3
Unchanged
0

LYFT INC

3.7M$34.3M1.9%$40.84-77.30%
15 qtrssince 2019-Q3
Decreased
0

RELAY THERAPEUTICS INC

1.6M$25.8M1.4%$41.71-60.51%
11 qtrssince 2020-Q3
Unchanged
0
DMDMDelisted

Desktop Metal Inc

11M$25.4M1.4%——
10 qtrssince 2020-Q4
Unchanged
0
BHILBHILDelisted

Benson Hill Inc

15.4M$17.7M1.0%——
7 qtrssince 2021-Q3
Unchanged
0
MEMEDelisted

23ANDME HOLDING CO

6.7M$15.4M0.9%——
6 qtrssince 2021-Q4
Unchanged
0

LYELL IMMUNOPHARMA INC

5.9M$13.8M0.8%$324.80-85.47%
8 qtrssince 2021-Q2
Unchanged
0

ILLUMINA INC

53,470$12.4M0.7%$394.56-42.67%
7 qtrssince 2021-Q3
Unchanged
0
$1.8B
AUM
49
Positions
Q1 2023
Filing
HI score · 2.0/5
Quarterly 13F Value Change
-2%Q4'21$4.1B-26%Q1'22$3.1B-40%Q2'22$1.8B+6%Q3'22$2B-12%Q4'22$1.7B+5%Q1'23$1.8B
Activity profile
$ moved · Q1'23
New0%Increased63%Decreased31%Exited5%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg <1 quarter
<1Q2%1-4Q98%1-2Y0%2Y+0%

Alphabet Inc. manages $1.8B across 49 positions as of Q1 2023. Top holdings: PATH (13.7%), PRME (9.1%), CRWD (8.9%). Fund DNA: Concentrated Value. HoldingsIntel Score: 2/5.0.

Q1 2023 Summary

Added MONDQ; exited NEWR, AMPL and VLD; increased 3, led by GTLB (+639,207 shares); trimmed 4, led by DUOL (−180,620 shares). Top move: CRWD (INCREASED, conviction 93). Portfolio: $1.8B across 49 positions.

Top holdings by portfolio weight

Total AUM$2B
PATH13.70%
PRME9.06%
CRWD8.86%
OSCR8.72%
VERV8.43%
DXCM8.05%
PL6.96%
EQRX5.13%
SNOW4.58%
DUOL4.14%
Other3.68%

Portfolio allocation by GICS sector

Sectors5
Technology40.35%
Healthcare32.70%
Unknown17.30%
Industrials6.97%
Financial Services2.68%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Technology, Healthcare, Unknown
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(2.0 / 5.0)
Holdings P&L42
Conviction36
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used